International Journal of Cancer Management

Published by: Kowsar

The Prognostic Value of Age, Sex, and Subsite in Cutaneous Head and Neck Melanoma: A Clinical Review of Recent Literature

Sameep Kadakia 1 , * , David Chan 2 , Moustafa Mourad 1 , * and Yadranko Ducic 2
Authors Information
1 Department of Otolaryngology-Head and Neck Surgery, New York Eye and Ear Infirmary of Mount Sinai, New York, USA
2 Department of Otolaryngology-Head and Neck Surgery, Facial Plastic Surgery Associates, Dallas-Fort Worth, Texas
Corresponding Authors:
Article information
  • Iranian Journal of Cancer Prevention: June 2016, 9 (3); e5079
  • Published Online: June 8, 2016
  • Article Type: Review Article
  • Received: December 18, 2015
  • Revised: January 21, 2016
  • Accepted: June 5, 2016
  • DOI: 10.17795/ijcp-5079

To Cite: Kadakia S, Chan D, Mourad M, Ducic Y. The Prognostic Value of Age, Sex, and Subsite in Cutaneous Head and Neck Melanoma: A Clinical Review of Recent Literature, Int J Cancer Manag. 2016 ; 9(3):e5079. doi: 10.17795/ijcp-5079.

Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann surg oncol. 2010; 17(6): 1471-4
  • 2. Marashi-Pour S, Morrell S, Cooke-Yarborough C, Arcorace M, Baker D. Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: a population-based study, 1988-2007. Aust N Z J Public Health. 2012; 36(5): 441-5[DOI][PubMed]
  • 3. Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ. 2012; 345[DOI][PubMed]
  • 4. Tseng WH, Martinez SR. Tumor location predicts survival in cutaneous head and neck melanoma. J Surg Res. 2011; 167(2): 192-8[DOI][PubMed]
  • 5. Kienstra MA, Padhya TA. Head and neck melanoma. Cancer Control. 2005; 12(4): 242-7[PubMed]
  • 6. Cheriyan J, Wernberg J, Urquhart A. Head and neck melanoma. Surg Clin North Am. 2014; 94(5): 1091-113[DOI][PubMed]
  • 7. Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol. 2009; 38(3): 814-30[DOI][PubMed]
  • 8. Caini S, Gandini S, Sera F, Raimondi S, Fargnoli MC, Boniol M, et al. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer. 2009; 45(17): 3054-63[DOI][PubMed]
  • 9. Elwood JM, Gallagher RP, Hill GB, Spinelli JJ, Pearson JC, Threlfall W. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. Br Med J (Clin Res Ed). 1984; 288(6411): 99-102[PubMed]
  • 10. Genetics of Skin Cancer. 2015;
  • 11. Kosary CL, Altekruse SF, Ruhl J, Lee R, Dickie L. Clinical and prognostic factors for melanoma of the skin using SEER registries: collaborative stage data collection system, version 1 and version 2. Cancer. 2014; 120 Suppl 23: 3807-14[DOI][PubMed]
  • 12. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol. 2004; 150(2): 179-85[PubMed]
  • 13. Scerri L, Aquilina S, Amato GA, Dalmas M. Sun awareness and sun protection practices in Malta. J Eur Acad Dermatol Venereol. 2002; 16(1): 47-52[PubMed]
  • 14. Mackie RM. Illustrated guide to recognition of early malignant melanoma. 1986;
  • 15. Cappello ZJ, Augenstein AC, Potts KL, McMasters KM, Bumpous JM. Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp. Laryngoscope. 2013; 123(6): 1411-5[DOI][PubMed]
  • 16. Monroe MM, Pattisapu P, Myers JN, Kupferman ME. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma. Otolaryngol Head Neck Surg. 2015; 153(3): 372-8[DOI][PubMed]
  • 17. Ciocan D, Barbe C, Aubin F, Granel-Brocard F, Lipsker D, Velten M, et al. Distinctive features of melanoma and its management in elderly patients: a population-based study in France. JAMA Dermatol. 2013; 149(10): 1150-7[DOI][PubMed]
  • 18. Stokes WA, Lentsch EJ. Age is an independent poor prognostic factor in cutaneous head and neck melanoma. Laryngoscope. 2014; 124(2): 462-5[DOI][PubMed]
  • 19. Shashanka R, Smitha BR. Head and neck melanoma. ISRN Surg. 2012; 2012: 948302[DOI][PubMed]
  • 20. Carlson GW, Murray DR, Lyles RH, Hestley A, Cohen C. Sentinel lymph node biopsy in the management of cutaneous head and neck melanoma. Plast Reconstr Surg. 2005; 115(3): 721-8[PubMed]
  • 21. Arce PM, Camilon PR, Stokes WA, Nguyen SA, Lentsch EJ. Is sex an independent prognostic factor in cutaneous head and neck melanoma? Laryngoscope. 2014; 124(6): 1363-7[DOI][PubMed]
  • 22. Joosse A, Collette S, Suciu S, Nijsten T, Lejeune F, Kleeberg UR, et al. Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol. 2012; 30(18): 2240-7[DOI][PubMed]
  • 23. Golger A, Young DS, Ghazarian D, Neligan PC. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study. Arch Otolaryngol Head Neck Surg. 2007; 133(5): 442-7[DOI][PubMed]
  • 24. Gillgren P, Brattstrom G, Frisell J, Persson JO, Ringborg U, Hansson J. Effect of primary site on prognosis in patients with cutaneous malignant melanoma. A study using a new model to analyse anatomical locations. Melanoma Res. 2005; 15(2): 125-32[PubMed]
  • 25. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol. 2008; 144(4): 515-21[DOI][PubMed]
  • 26. de Giorgi V, Rossari S, Gori A, Grazzini M, Savarese I, Crocetti E, et al. The prognostic impact of the anatomical sites in the 'head and neck melanoma': scalp versus face and neck. Melanoma Res. 2012; 22(5): 402-5[DOI][PubMed]
  • 27. Wanebo HJ, Cooper PH, Young DV, Harpole DH, Kaiser DL. Prognostic factors in head and neck melanoma. Effect of lesion location. Cancer. 1988; 62(4): 831-7[PubMed]
  • 28. Ballantyne AJ. Malignant melanoma of the skin of the head and neck. An analysis of 405 cases. Am J Surg. 1970; 120(4): 425-31[PubMed]
  • 29. Leong SP, Accortt NA, Essner R, Ross M, Gershenwald JE, Pockaj B, et al. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaryngol Head Neck Surg. 2006; 132(4): 370-3[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments